Skip to main content
Molecular Hiving

Bachem in Molecular Hiving deal

Bachem, the world’s largest producer of pharmaceutical peptides and ologonucleotides, has signed an exclusive licensing agreement with Japanese firm Jitsubo related to the latter’s liquid-phase peptide technology. Molecular Hiving. Financial terms were not disclosed. The two firms have already worked together on APIs and cosmetic peptides.

Under the new deal, Jitsubo will develop selected manufacturing processes using Molecular Hiving and transfer them to Bachem for further optimisation, scale-up and commercial production, in return for development fees and royalties. Bachem said that it expects to achieve “reduced manufacturing costs, improved sustainability, greener chemistry, efficient scale up and enhanced in-process controls”.

Add new comment

Plain text

  • No HTML tags allowed.
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

 

 

 

AMRI banner advert